Company Quick10K Filing
Reva Medical
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-07
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-03-10
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-17
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-27
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-30
8-K 2020-02-26
8-K 2020-01-14
8-K 2019-12-13
8-K 2019-08-06
8-K 2019-04-02
8-K 2019-03-29
8-K 2019-03-12
8-K 2019-03-05
8-K 2019-02-25
8-K 2019-02-19
8-K 2019-02-17
8-K 2019-02-04
8-K 2019-01-14
8-K 2019-01-02
8-K 2018-11-14
8-K 2018-11-05
8-K 2018-11-05
8-K 2018-09-22
8-K 2018-08-07
8-K 2018-07-30
8-K 2018-07-30
8-K 2018-07-25
8-K 2018-06-26
8-K 2018-05-23
8-K 2018-05-23
8-K 2018-05-16
8-K 2018-05-16
8-K 2018-03-22
8-K 2018-03-13
8-K 2018-03-07
8-K 2018-02-28
8-K 2018-02-05
8-K 2018-01-08

Reva Medical Financials

RVA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash72,98064,97159,16154,57449,54744,33738,87636,03531,02225,96619,22913,0328,9796,29725,81420,58315,88111,84516,89522,07316,54911,5536,6741,71029,14724,10020,00014,90010,9007,094
Accounts Receivable65636984115
Inventory506370627945860831
PP&E1,1751,2741,9602,7595,8716,0246,2236,4167,0707,5337,8577,9538,0028,0468,1968,4678,5998,8758,9889,1639,4059,5719,6719,0399,1799,3018,7288,7819,3879,528
Assets74,47170,69467,32062,54057,56752,61847,39741,76136,70631,05724,78517,86113,3119,93930,19524,93020,19915,57620,07125,14119,47114,2699,4834,26832,07126,68322,66118,60114,53710,626
Accounts Payable6227181,2848429876496566491,1361,1211,4008807026236516328757111,0541,3138278837787539493637568491,0701,010
Long-Term Debt37,78049,99043,05057,54075,36599,17296,20691,65583,517
Liabilities1,4831,6412,7372,4992,6292,5812,7712,4843,0313,5503,9603,0002,2412,45856,64474,12162,70491,807100,635105,314102,311120,36899,07691,525131,347120,699115,47486,89779,65983,896
Stockholders' Equity72,98869,05364,58360,04154,93850,03744,62639,27733,67527,50720,82514,86111,0707,481-26,449-49,191-42,505-76,231-80,564-80,173-82,840-106,099-89,593-87,257-99,276-94,016-92,813-68,296-65,122-73,270
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue1728539193
Cost of Revenue73556121141
Gross Profit10-7-3-30-48
R&D3,4862,9573,7173,7994,8663,9284,0714,1974,5825,0885,3454,8792,9732,9303,5363,2644,0674,4045,0255,2884,6654,2124,0063,9643,0833,0922,6212,4352,5051,729
SG&A1,9281,7472,0921,9222,1011,9212,2742,1462,0842,0942,4072,3931,8591,5161,8771,5891,5661,8182,2372,1932,3661,9372,1132,1021,9771,6872,8063,2943,1352,821
Tax000000000000000000
Net Income-5,351-4,655-5,769-5,698-5,915-5,834-6,329-6,331-6,647-7,191-7,753-7,276-4,833-4,397-34,531-23,3575,854-34,868-30,223-40,798-4,555-23,94315,1981,424-5036,05316023,3431,927-9,036
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-3,573-4,980-4,549-4,199-4,574-5,240-5,380-5,067-6,229-6,649-4,180-3,291-3,810-4,962-4,475-4,447-5,198-6,038-5,366-4,742-5,113-4,889-5,041-4,910-4,018-5,144-3,512
Cash Investing-4,444-1,269-347-828-648-2222,53911-520282127700-1,153-281-227252394-199-171-254-105-75-89-1,641-51231467
Cash Financing10439309112000121700-9124,4801201599,85411,415130339170